Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer

Background. Tumor necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) is a death ligand currently under clinical trials for cancer. The molecular profile of TRAIL and TRAIL receptors has not yet been mapped for patients with laryngeal squamous cell carcinoma (SCC) or patients with oral c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Head & neck 2011-09, Vol.33 (9), p.1278-1284
Hauptverfasser:	Yoldas, Burcak, Ozer, Cem, Ozen, Ozlem, Canpolat, Tuba, Dogan, Isilay, Griffith, Thomas S., Sanlioglu, Salih, Ozluoglu, Levent N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Carcinoma, Squamous Cell - metabolism Carcinoma, Squamous Cell - pathology Case-Control Studies clinical and pathologic staging Female head and neck cancer Humans Immunohistochemistry Laryngeal Neoplasms - metabolism Laryngeal Neoplasms - pathology Male Medical sciences Middle Aged molecular diagnostics Mouth Neoplasms - metabolism Mouth Neoplasms - pathology Otorhinolaryngology (head neck, general aspects and miscellaneous) Otorhinolaryngology. Stomatology Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism Retrospective Studies TNF-Related Apoptosis-Inducing Ligand - metabolism TRAIL TRAIL receptor Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!